ABOUT KEYTRUDA LAWSUIT

Keytruda is really a brand (trade) name for pembrolizumab. It really is given by intravenous infusion every 3 to six weeks. Rarely, the use of Keytruda results while in the immune system attacking nutritious tissues and this can cause severe side effects including pneumonitis, colitis, or hepatitis. In a lot of people, using Keytruda has resulted w